vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and NATIONAL RESEARCH CORP (NRC). Click either name above to swap in a different company.
NATIONAL RESEARCH CORP is the larger business by last-quarter revenue ($35.2M vs $19.2M, roughly 1.8× Apyx Medical Corp). NATIONAL RESEARCH CORP runs the higher net margin — 5.1% vs -6.8%, a 11.9% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -4.6%). NATIONAL RESEARCH CORP produced more free cash flow last quarter ($6.1M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs -0.2%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska.
APYX vs NRC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $35.2M |
| Net Profit | $-1.3M | $1.8M |
| Gross Margin | 62.6% | — |
| Operating Margin | 0.1% | 13.3% |
| Net Margin | -6.8% | 5.1% |
| Revenue YoY | 34.7% | -4.6% |
| Net Profit YoY | 71.9% | -72.6% |
| EPS (diluted) | — | $49.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $35.2M | ||
| Q3 25 | $12.9M | $34.6M | ||
| Q2 25 | $11.4M | $34.0M | ||
| Q1 25 | $9.4M | $33.6M | ||
| Q4 24 | $14.2M | $36.9M | ||
| Q3 24 | $11.5M | $35.8M | ||
| Q2 24 | $12.1M | $35.0M | ||
| Q1 24 | $10.2M | $35.3M |
| Q4 25 | $-1.3M | $1.8M | ||
| Q3 25 | $-2.0M | $4.1M | ||
| Q2 25 | $-3.8M | $-106.0K | ||
| Q1 25 | $-4.2M | $5.8M | ||
| Q4 24 | $-4.6M | $6.6M | ||
| Q3 24 | $-4.7M | $5.7M | ||
| Q2 24 | $-6.6M | $6.2M | ||
| Q1 24 | $-7.6M | $6.4M |
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 58.1% | — |
| Q4 25 | 0.1% | 13.3% | ||
| Q3 25 | -6.5% | 22.4% | ||
| Q2 25 | -22.6% | 4.7% | ||
| Q1 25 | -32.4% | 25.6% | ||
| Q4 24 | -21.4% | 26.0% | ||
| Q3 24 | -31.6% | 22.3% | ||
| Q2 24 | -45.7% | 25.3% | ||
| Q1 24 | -64.6% | 24.8% |
| Q4 25 | -6.8% | 5.1% | ||
| Q3 25 | -15.4% | 11.9% | ||
| Q2 25 | -33.2% | -0.3% | ||
| Q1 25 | -44.0% | 17.2% | ||
| Q4 24 | -32.5% | 17.8% | ||
| Q3 24 | -40.9% | 15.9% | ||
| Q2 24 | -54.0% | 17.6% | ||
| Q1 24 | -74.0% | 18.0% |
| Q4 25 | — | $49.58 | ||
| Q3 25 | — | $0.18 | ||
| Q2 25 | — | $-0.01 | ||
| Q1 25 | — | $0.25 | ||
| Q4 24 | — | $0.27 | ||
| Q3 24 | — | $0.24 | ||
| Q2 24 | $-0.19 | $0.26 | ||
| Q1 24 | $-0.22 | $0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $4.1M |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $14.0M |
| Total Assets | $66.8M | $134.9M |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $4.1M | ||
| Q3 25 | $25.1M | $2.2M | ||
| Q2 25 | $29.3M | $5.3M | ||
| Q1 25 | $31.0M | $2.5M | ||
| Q4 24 | $31.7M | $4.2M | ||
| Q3 24 | $28.0M | $3.5M | ||
| Q2 24 | $32.7M | $485.0K | ||
| Q1 24 | $37.3M | $1.7M |
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | $48.7M | ||
| Q2 24 | — | $33.3M | ||
| Q1 24 | — | $35.2M |
| Q4 25 | $14.5M | $14.0M | ||
| Q3 25 | $5.8M | $14.3M | ||
| Q2 25 | $7.3M | $21.3M | ||
| Q1 25 | $10.5M | $29.7M | ||
| Q4 24 | $14.2M | $31.3M | ||
| Q3 24 | $11.0M | $34.6M | ||
| Q2 24 | $14.7M | $40.2M | ||
| Q1 24 | $20.3M | $36.9M |
| Q4 25 | $66.8M | $134.9M | ||
| Q3 25 | $57.4M | $135.7M | ||
| Q2 25 | $58.2M | $141.4M | ||
| Q1 25 | $60.2M | $135.2M | ||
| Q4 24 | $64.8M | $132.5M | ||
| Q3 24 | $60.7M | $131.8M | ||
| Q2 24 | $65.4M | $119.1M | ||
| Q1 24 | $70.7M | $120.9M |
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | 1.41× | ||
| Q2 24 | — | 0.83× | ||
| Q1 24 | — | 0.95× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $7.2M |
| Free Cash FlowOCF − Capex | $-2.8M | $6.1M |
| FCF MarginFCF / Revenue | -14.6% | 17.2% |
| Capex IntensityCapex / Revenue | 1.4% | 3.2% |
| Cash ConversionOCF / Net Profit | — | 3.99× |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $15.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $7.2M | ||
| Q3 25 | $-3.5M | $13.8M | ||
| Q2 25 | $-1.2M | $-1.1M | ||
| Q1 25 | $-702.0K | $6.6M | ||
| Q4 24 | $-2.9M | $6.4M | ||
| Q3 24 | $-4.4M | $9.4M | ||
| Q2 24 | $-4.3M | $6.8M | ||
| Q1 24 | $-6.3M | $12.0M |
| Q4 25 | $-2.8M | $6.1M | ||
| Q3 25 | $-4.1M | $10.2M | ||
| Q2 25 | $-1.5M | $-4.1M | ||
| Q1 25 | $-757.0K | $3.7M | ||
| Q4 24 | $-3.2M | $1.9M | ||
| Q3 24 | $-4.6M | $7.8M | ||
| Q2 24 | $-4.6M | $1.5M | ||
| Q1 24 | $-6.4M | $7.9M |
| Q4 25 | -14.6% | 17.2% | ||
| Q3 25 | -31.5% | 29.4% | ||
| Q2 25 | -13.2% | -12.2% | ||
| Q1 25 | -8.0% | 10.9% | ||
| Q4 24 | -22.4% | 5.2% | ||
| Q3 24 | -40.0% | 21.8% | ||
| Q2 24 | -38.0% | 4.3% | ||
| Q1 24 | -62.2% | 22.4% |
| Q4 25 | 1.4% | 3.2% | ||
| Q3 25 | 4.0% | 10.4% | ||
| Q2 25 | 2.3% | 8.8% | ||
| Q1 25 | 0.6% | 8.9% | ||
| Q4 24 | 1.7% | 12.0% | ||
| Q3 24 | 1.3% | 4.5% | ||
| Q2 24 | 2.4% | 15.0% | ||
| Q1 24 | 0.3% | 11.7% |
| Q4 25 | — | 3.99× | ||
| Q3 25 | — | 3.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.15× | ||
| Q4 24 | — | 0.97× | ||
| Q3 24 | — | 1.66× | ||
| Q2 24 | — | 1.10× | ||
| Q1 24 | — | 1.89× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
